Outcome Comparison of Transurethral Resection of the Prostate in Benign Prostatic Hyperplasia Patients in Karawang General Referral Hospital

Ramlan Halimi* -  Departement of Urology, Faculty of Medicine University of Indonesia-Cipto Mangunkusumo General Hospital, Jakarta, Indonesia
Achmad Rizky Herda Pratama -  Department of Urology, Karawang General Referral Hospital, West Java,, Indonesia

DOI : 10.33371/ijoc.v13i3.652

Background: Benign Prostatic Hyperplasia (BPH) is the most common pathological condition in man that causes Lower Urinary Tract Syndrome (LUTS). The most popular therapeutic modality for BPH is Transurethral Resection of Prostate (TURP). This study describes the TURP outcome in BPH patient with prostate size > 75 grams compared to < 75 grams in Karawang General Referral Hospital.

Methods: We performed a retrospective review of clinical outcome from BPH patient with LUTS who underwent TURP procedure between January 2017 – April 2018. Data was taken through patient medical records and processed descriptively to describe complications, quality of life, and clinical laboratory data. Qualitative data compared with Chi-Square test.

Results: During this study, we evaluated 40 patients, 20 patients with prostate size > 75 grams (group 1) and 20 patients with prostate size < 75 grams (group 2). Mean age in group 1 was 65.6 ± 9.9 years and in group 2 was 65.3 ± 10.2 years. International Prostate Symptom Score (IPSS) after TURP between group 1 and group 2 showed a significant difference, while incomplete emptying was found mostly in group 2 (p < 0.05). There was no significant difference in Quality of Life Score between group 1 and group 2 (p > 0.05). From laboratory results, we found a reduction of hemoglobin in both groups with p-value < 0.05 or no significant difference.

Conclusions: Transurethral Resection of Prostate (TURP) procedure for patient with prostate size > 75 grams is safe and effective with lower complications and there is no significant difference compared to patient with prostate size < 75 grams.

Keywords
benign prostatic hyperplasia, outcome, TURP
  1. Joshi HN, de Jong IJ, Karmacharya RM, Shrestha B, Shrestha R. Outcomes of transurethral resection of the prostate in benign prostatic hyperplasia comparing prostate size of more than 80 grams to prostate size less than 80 grams. Kathmandu University Medical Journal. 2014;12:163-7.
  2. Roehrborn CG. Benign Prostatic Hyperplasia: Etiology, Pathophysiology, Epidemiology, and Natural History. In Wein AJ (eds) Campbell-Walsh Urology 11th. Elsevier; 2016. pp 2425-662.
  3. Al-Hammouri F, Abu-Qamar A. Monopolar Transurethral resection of the big prostate, experience at Prince Hussein Bin Abdullah Urology Center. J Pak Med Assoc. 2011;61:628-31.
  4. Kallenberg F, Hossack TA, Woo HH. Long-term follow-up after electrocautery transurethral resection of the prostate for benign prostatic hyperplasia. Adv Urol. 2011;20;1-6.
  5. Palaniappan S, Kuo TL, Cheng CW, Foo KT. Early outcome of transurethral enucleation and resection of the prostate versus transurethral resection of the prostate. Singapore Med J. 2016;57(12):676-680.
  6. Madduri VK, Bera MK, Pal DK. Monopolar versus bipolar transurethral resection of prostate for benign prostatic hyperplasia: Operative outcomes and surgeon preferences, a real-world scenario. Urology Annals. 2016;8:291-96.
  7. Mochtar CA, Umbas R, Soebadi DM, Rasyid N, Noegroho BS, Poernomo BB et al. Panduan penatalaksanaan klinis pembesaran prostat jinak. Ikatan Ahli Urologi Indonesia (IAUI). 2015;2:1-27.
  8. Tang J, Yang J. Etiopathogenesis of benign prostatic hyperplasia. Ind J Urol.2009;25:312-7.
  9. Abrams P, Chpple C, Khoury S, Roehrborn C, de La Rosette J. International Scientific committee. Evaluation and treatment of lower urinary tract symptoms in older men. J Urol. 2009;81:1779-87.
  10. Djavan B, Nickel JC, De La Rosette J, Abrams P. The Urologist view of BPH progression: results of an international survey. Eur Urol. 2002;41:490-6.
  11. Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. J Urol. 1984;132:474-9.
  12. Yucel M, Aras B, Yalcinkaya S, Hatipoglu NK, Aras E. Conventional monopolar transurethral resection of prostate in patients with large prostate (>/- 80 grams). Cent European J Urol. 2013;66(3):303-308.
  13. Elssayed EO, Mansour MI, Eliman M. Clinical appraisal of TURP in Gezira Hospital for renal diseases and surgery. Global Journal of medical research surgeries and cardiovascular system. 2013;13:13-7.
  14. Olumi AF, Richie JP. Urologic Surgery. In: Townsend CR, Beauchamp RD, Evers BM, Mattox KL (editors). Sabiston Textbook of Surgery, 18th ed. Sunders Elsevier; 2008. pp 2251-2285.
  15. Madersbacher S, Marberg M. Is the transurethral resection of prostate still justified? BJU Int. 1999;83:227-37.
  16. Madersbacher S, Lackner J, Brossner C, Rochlich M, Stancik I, Willinger M, et al. Prostate Study Group of the Austrian Society of Urology. Reoperation, myocardial Infarction and mortality after transurethral and open prostatectomy: a nation-wide, long-term analysis of 23,123 cases. Eur Urol. 2005;47:499-504.
  17. Mebust WK, Roizo R, Schroeder F, Villers A. Correlations between pathology, clinical symptoms and course of the disease. The International Consultation on Benign Prostatic Hyperplasia- Proceedings. Paris; 1991. pp 51-62.
  18. May F, Hartung R. Surgical atlas. Transurethral resection of the prostate. BJU Int. 2006;98(4):921-34.
  19. Fitzpatrick JM. Millin retropubic prostatectomy. In Hohenfellner R (eds) Advanced Urologic Surgery. Wiley-Blackwell; 2005. pp 139-41.
  20. Kirby RS. Progressive development of benign prostatic hyperplasia. In; Kirby RS (eds) An atlas prostatic diseases 3rd edition. London: CRC Press; 2003. pp 58-62.
  21. Hinman F, Stempen PH. Anatomy and principles of excision of the prostate. In: Hinman Jr (eds) Atlas of Urologic Surgery 2nd edition. Saunders; 2010. pp 412-64.
  22. Stern JA, Fitzpatrick JM, McVary KT. Prostate anatomy and causative theories pathophysiology and natural history of benign prostatic hyperplasia. In: McVary KT (eds) Management of benign prostatic hypertrophy. New York: Humana Press; 2004. pp 1-19.
  23. Donahue TF, Costa JA. Transurethral needle ablation of the prostate. In: McVary KT (eds) Management of benign prostatic hypertrophy. New York: Humana Press; 2004. pp 97-108.
  24. Foster HE, Jacobs M. Transurethral resection of the prostate. In: McVary KT (eds) Management of benign prostatic hypertrophy. New York: Humana Press; 2004. pp 163-93.
  25. Kozlowski JM, Smith ND, Grayhack JT. Suprapubic transvesical prostatectomy and simple perineal prostatectomy for the treatment of benign prostatic hyperplasia. In: McVary KT (eds) Management of benign prostatic hypertrophy. New York: Humana Press; 2004. pp 221-62.
  26. Connolly SS, Fitzpatrick JM. Complication of open prostate surgery. In: Loughlin KR (eds) Complications in urologic surgery and practice. London: CRC Press; 2007. pp 129-35.
  27. Helfand BT, McVary KT. Complication of minimally invasive treatments for lower urinary tract symptoms secondary to benign prostatic hyperplasia. In: Loughlin KR (eds) Complications in urologic surgery and practice. London: CRC Press; 2007. pp 393-423.
  28. Kursh ED. Evaluation and treatment of benign prostatic hyperplasia. In: Potts JM (eds) Essential Urology 1st edition. Totowa NJ: Humana Press; 2004. pp 191-202.
  29. Jacobsen SJ, Girman CJ, Lieber MM. Natural history of benign prostatic hyperplasia. Urology. 2001;58:5-16.
  30. Hegarty P, Fitzpatrick JM, Bruskewitz. Medical management – watchful waiting. In Kirby RS, McConnell JD, Fitzpatrick J, Roehrborn CG, Wyllie M, Boyle P (eds) Therapeutic treatment for benign prostatic hyperplasia. London: CRC Press; 2005. pp 1-9.
  31. Ceylan K. Open prostatectomy the result of a series of 320 cases in rural area. Eur J Gen Med. 2006;3(1):11-15.

Full Text:
Article Info
Submitted: 2019-05-06
Published: 2019-10-16
Section: Research Articles
Article Statistics: 31 29